Detalhe da pesquisa
1.
Other Primary Malignancies in Patients with Breast Cancer Who Undergo Germline Panel Testing.
Ann Surg Oncol;
30(3): 1663-1668, 2023 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36094691
2.
Contralateral Prophylactic Mastectomy among Women with Pathogenic Variants in BRCA1/2: Overall Survival, Racial, and Ethnic Differences.
Breast J;
2022: 1447545, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36685664
3.
Contralateral Risk-Reducing Mastectomy in Breast Cancer Patients Who Undergo Multigene Panel Testing.
Ann Surg Oncol;
27(12): 4613-4621, 2020 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32720048
4.
Clinical outcome and toxicity from taxanes in breast cancer patients with BRCA1 and BRCA2 pathogenic germline mutations.
Breast J;
26(8): 1572-1582, 2020 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32497289
5.
Elevated serum levels of sialyl Lewis X (sLeX) and inflammatory mediators in patients with breast cancer.
Breast Cancer Res Treat;
176(3): 545-556, 2019 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31054033
6.
BRCA mutations in women with inflammatory breast cancer.
Cancer;
124(3): 466-474, 2018 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29044548
7.
Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancer.
Breast Cancer Res Treat;
158(1): 67-77, 2016 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27287781
8.
High incidence of germline BRCA mutation in patients with ER low-positive/PR low-positive/HER-2 neu negative tumors.
Cancer;
121(19): 3422-7, 2015 Oct 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26280679
9.
Genotype-Phenotype Correlations by Ethnicity and Mutation Location in BRCA Mutation Carriers.
Breast J;
21(3): 260-7, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25789811
10.
Predictors that influence contralateral prophylactic mastectomy election among women with ductal carcinoma in situ who were evaluated for BRCA genetic testing.
Ann Surg Oncol;
21(11): 3466-72, 2014 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24796968
11.
Reply to Diagnosis of patients with inflammatory breast cancer is a problematic issue.
Cancer;
124(4): 866, 2018 02 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29266209
12.
Genotype in BRCA-associated breast cancers.
Breast J;
19(1): 87-91, 2013.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23231005
13.
Validating risk prediction models for multiple primaries and competing cancer outcomes in families with Li-Fraumeni syndrome using clinically ascertained data at a single institute.
medRxiv;
2023 Sep 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37693464
14.
Predictive factors for BRCA1/BRCA2 mutations in women with ductal carcinoma in situ.
Cancer;
118(6): 1515-22, 2012 Mar 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22009639
15.
Early onset HER2-positive breast cancer is associated with germline TP53 mutations.
Cancer;
118(4): 908-13, 2012 Feb 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21761402
16.
Clinical outcomes and Oncotype DX Breast Recurrence Score® in early-stage BRCA-associated hormone receptor-positive breast cancer.
Cancer Med;
11(6): 1474-1483, 2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35128817
17.
Incidence and impact of brain metastasis in patients with hereditary BRCA1 or BRCA2 mutated invasive breast cancer.
NPJ Breast Cancer;
8(1): 46, 2022 Apr 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35393462
18.
Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations.
Breast Cancer Res Treat;
130(1): 145-53, 2011 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21830012
19.
Imaging Features of Triple Negative Breast Cancer and the Effect of BRCA Mutations.
Curr Probl Diagn Radiol;
50(3): 303-307, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32033821
20.
Biomarker Modulation Study of Celecoxib for Chemoprevention in Women at Increased Risk for Breast Cancer: A Phase II Pilot Study.
Cancer Prev Res (Phila);
13(9): 795-802, 2020 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32513785